Snap-8
Also known as Acetyl Octapeptide-3, Acetyl Glutamyl Heptapeptide-1
A cosmetic neuropeptide ingredient related to Argireline concepts, marketed for expression-line reduction through topical modulation of facial muscle signaling.
Overview
Snap-8 is a cosmetic peptide ingredient, not an injectable therapeutic peptide. It is marketed in topical skin-care products for expression lines and facial-skin appearance.
The Science
Snap-8 is usually positioned as an expanded analog of acetyl hexapeptide-8 concepts, aiming at superficial modulation of neurotransmission-related pathways in facial expression lines.
- Topical delivery - skin penetration and formulation drive plausibility.
- Cosmetic endpoints - wrinkle depth and appearance, not disease treatment.
- SNARE-related claims - mechanistic language should be read carefully and not equated with botulinum toxin.
Evidence Snapshot
Snap-8 belongs in cosmetic ingredient literacy. Claims are formulation-dependent and should not be treated as equivalent to medical neuromodulators.
Related
More in Healing & Recovery
ARA-290
InvestigationalHealing & Recovery
An erythropoietin-derived peptide studied for tissue-protective and anti-inflammatory signaling without the red-blood-cell stimulation associated with EPO.
Botulinum Toxin
FDA-approvedHealing & Recovery
Not a peptideProtein toxin
A bacterial neurotoxin protein used clinically in tightly controlled doses for neuromuscular, migraine, autonomic, and cosmetic indications; it is not a peptide supplement.
BPC-157
Research compoundHealing & Recovery
A stable 15-amino-acid peptide fragment derived from a protein in human gastric juice, widely studied in preclinical models for tissue protection and repair across gut, tendon, muscle, and vascular tissue.